Delivery Order SPE2DB20D3111-SPE2DB25FA9BX
- Not listed
- The Defense Logistics Agency awarded a $2,826.40 delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/ML pens (3ML) on June 17, 2025, with an ultimate completion date of June 18, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's significant $999,999,999...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.96 to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/ML pens (3ML) with a firm fixed price structure. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, and is not designated as a set-aside contract. This delivery order represents a competitive award exercised under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,637.56 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,298,990 units of Insulin Aspart 100 Unit/mL pen 3mL. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA to efficiently procure a...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $20,447.41 firm-fixed-price delivery order (SPE2DX15D3003|SPE2DX24F5Q4Z) to AmerisourceBergen Drug Corp's Corporate Office division for 4,565,844,165 units of Insulin Aspart 100 Unit/mL Pen 3mL. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563449313 - Insulin Aspart 100 Unit/mL Pen 3mL. The contract has a potential value of $3,329.97 and a completion date of January 26, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,337,566 units of Insulin Aspart 100 Unit/mL Pen 3mL. The $12,081.09 delivery order has a completion date of January 17, 2024 and was awarded on January 16, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has previously received numerous federal contracts from DLA Troop Support Medical to supply...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,206.40 firm-fixed-price contract is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML, a specialty pharmaceutical product. The order has a completion date of November 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $1,300.68 to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL pens (3mL) under a firm fixed price contract. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a non-set-aside, competitively awarded transaction and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,847.21, is for the delivery of insulin aspart 100 unit/mL pen 3mL. The contract has a completion date of June 27, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- The Defense Logistics Agency awarded a $27,740 delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/mL pens (3mL) with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order, awarded on September 26, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-competitive delivery order issued under an existing contract vehicle, reflecting AmerisourceBergen's established...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA9BXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/ML pen 3ML under a firm fixed price contract with a ceiling value of $4,145.26. The award was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of medications, vaccines, and medical devices to support military and veteran healthcare systems. The DLA Troop Support Medical IDC serves as a global pharmaceutical support vehicle enabling the company to fulfill federal medical supply requirements across multiple therapeutic domains. This delivery order for insulin aspart exemplifies the company's role in supporting military healthcare programs with essential pharmaceutical products through a flexible and competitive contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 8/26/25 |